Invasive Breast Carcinoma — Trials

Invasive Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

296 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 103
Recruiting: 41
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (43)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03970967	Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases	terminated	N/A	1	Alpha Tau Medical LTD.INDUSTRY	1	Jan 18, 2024	clinicaltrials
NCT03630653	Sentinel Lymph Node Procedure in Ipsilateral Invasive Breast Cancer Relapse(FIGARO)	terminated	N/A	50	Institut Cancerologie de l'OuestOTHER	1	Apr 25, 2022	clinicaltrials